{
    "summary": "We recommend using a newer internet browser, such as Google Chrome or\nMicrosoft Edge, to optimize your browsing experience.\n\nClose\n\nSkip to main content\n\nSearch\n\nSearch\n\nClear\n\nPress to close the select your country window or navigate to it's content\n\n### Find more information about Teva in your location, or contact a local\nrepresentative on our local sites\n\n## North America\n\n  * Canada \n\n  * United States \n\n## International Markets\n\n  * Argentina \n\n  * Australia \n\n  * Belarus \n\n  * Brazil \n\n  * Chile \n\n  * China \n\n  * Hong Kong SAR \n\n  * India \n\n  * Indonesia \n\n  * Israel \n\n  * Japan \n\n  * Kazakhstan \n\n  * Kyrgyzstan \n\n  * Mexico \n\n  * New Zealand \n\n  * Peru \n\n  * Russia \n\n  * Singapore \n\n  * South Africa \n\n  * South Korea \n\n  * Thailand \n\n  * Turkey \n\n  * Ukraine \n\n  * Uruguay \n\n## Europe\n\n  * Austria \n\n  * Belgium \n\n  * Bosnia and Herzegovina \n\n  * Bulgaria \n\n  * Croatia \n\n  * Czech Republic \n\n  * Denmark \n\n  * Estonia \n\n  * Finland \n\n  * France \n\n  * Germany \n\n  * Greece \n\n  * Hungary \n\n  * Iceland \n\n  * Ireland \n\n  * Italy \n\n  * Latvia \n\n  * Lithuania \n\n  * Macedonia \n\n  * Malta \n\n  * Netherlands \n\n  * Norway \n\n  * Poland \n\n  * Portugal \n\n  * Romania \n\n  * Serbia \n\n  * Slovakia \n\n  * Slovenia \n\n  * Spain \n\n  * Sweden \n\n  * Switzerland \n\n  * United Kingdom \n\n#### North America\n\nToggle\n\n  * Canada \n\n  * United States \n\n#### International Markets\n\nToggle\n\n  * Argentina \n\n  * Australia \n\n  * Belarus \n\n  * Brazil \n\n  * Chile \n\n  * China \n\n  * Hong Kong SAR \n\n  * India \n\n  * Indonesia \n\n  * Israel \n\n  * Japan \n\n  * Kazakhstan \n\n  * Kyrgyzstan \n\n  * Mexico \n\n  * New Zealand \n\n  * Peru \n\n  * Russia \n\n  * Singapore \n\n  * South Africa \n\n  * South Korea \n\n  * Thailand \n\n  * Turkey \n\n  * Ukraine \n\n  * Uruguay \n\n#### Europe\n\nToggle\n\n  * Austria \n\n  * Belgium \n\n  * Bosnia and Herzegovina \n\n  * Bulgaria \n\n  * Croatia \n\n  * Czech Republic \n\n  * Denmark \n\n  * Estonia \n\n  * Finland \n\n  * France \n\n  * Germany \n\n  * Greece \n\n  * Hungary \n\n  * Iceland \n\n  * Ireland \n\n  * Italy \n\n  * Latvia \n\n  * Lithuania \n\n  * Macedonia \n\n  * Malta \n\n  * Netherlands \n\n  * Norway \n\n  * Poland \n\n  * Portugal \n\n  * Romania \n\n  * Serbia \n\n  * Slovakia \n\n  * Slovenia \n\n  * Spain \n\n  * Sweden \n\n  * Switzerland \n\n  * United Kingdom \n\nClose\n\n  * Investors\n  * News & Media\n\nSelect your location\n\nSearch\n\n  * Our Company Show Submenu\n\n    * Our Purpose \n    * Leadership and Corporate Governance Show Submenu\n\n      * Corporate Officers \n      * Board of Directors \n      * Governance & Policy Documents \n\n    * Our Values \n    * Teva Facts & Figures \n    * Our History \n    * Teva\u2019s Global Supply Chain \n    * Compliance and Integrity \n\nAs a global leader in generic medicines with a strong innovative portfolio, we\nare all in for better health.\n\n  * Product Focus Show Submenu\n\n    * Generic Medicines \n    * Innovative Therapeutic Areas \n    * Biopharmaceuticals \n    * Research & Development Show Submenu\n\n      * Our Pipeline \n      * Clinical Trials \n      * Collaborative Research & ISS \n\n    * Medical Information \n    * Consumer Healthcare \n    * Out-Licensing Generic Pharmaceuticals \n    * Teva api \n    * Quality Products \n\nQuality, accessibility, and innovation, without compromise\n\n  * Patients & Caregivers Show Submenu\n\n    * Life Effects \n    * Caregivers \n    * Humanizing Health \n    * Patient Safety \n    * COVID Updates \n    * Antimicrobial Resistance \n    * Clinical Trials \n\n  * Our Impact Show Submenu\n\n    * ESG Progress Report \n    * Access to Medicine \n    * Protecting our Planet \n    * Ethics & Compliance \n    * Economic Impact \n    * Responsible Suppliers \n    * Community Giving \n\nActing responsibly and ethically in all we do helps ensure our\nsustainability\u2014allowing Teva to provide treatments to those who need them for\nyears to come.\n\n  * Your Career Show Submenu\n\n    * What we do \n    * Inclusion & Diversity Show Submenu\n\n      * Gender Equality \n      * Celebrating Pride at Teva \n\n    * Life at Teva \n    * Growth at Teva \n    * Benefits & Wellbeing \n    * Changing Industry \n    * How we Hire \n    * Our People \n\nWorking at Teva is not just a job, it\u2019s so much more than that. Here, you get\nto spend each day helping millions of people around the world enjoy healthier\nlives. At the same time, you\u2019ll be joining a dedicated team, united by the\nstrong sense that we\u2019re building something greater than ourselves.\n\n  * Contact Us \n\nMenu\n\n# We are all in for better health\n\n## ****\n\n****\n\n#### View the video transcript\n\nToggle Transcript expand and collapse\n\n**Teva 2023 End of Year Highlights**\n\nIt\u2019s been a year of change, in which we embarked on our new Pivot to Growth\nstrategy,\n\npivoting towards long-term growth, further innovation, and even greater\nresilience.\n\nAnd we stood united with our Israeli colleagues,\n\noffering support and helping to ensure the continued delivery of essential\nmedicines to our patients.\n\nAs we evolve\u2026\n\nWe are becoming **Stronger**\n\nHoning our generics leadership, focusing on complex generics and biosimilars,\n\nand streamlining development and launches\n\nin order to help create more value for patients and healthcare systems.\n\nWe are becoming **Bolder**\n\nLaunching an important new treatment for schizophrenia,\n\nand a treatment for movement disorders in the US.\n\nAdvancing our robust pipeline to support more patients with various\nconditions.\n\nAnd partnering to deliver value and exciting new treatments.\n\nWe are becoming **Simpler**\n\nFocusing on what matters. Moving forward with a clear sense of purpose.\n\nIt\u2019s been a year of transformation.\n\nIt\u2019s time to keep that momentum going and drive our business toward a better\ntomorrow.\n\nOne we are all proud of.\n\nStronger. Bolder. Simpler.\n\nBring on 2024.\n\nWe are all in for better health.\n\nWe are Teva.\n\n### Becoming stronger, bolder, and simpler\n\nAt Teva, our shared purpose keeps us moving together and pushing the\nboundaries to deliver high-quality medicines. Take a glimpse into the special\nyear we've had in 2023.\n\n## Becoming stronger, bolder, and simpler\n\nAt Teva, our shared purpose keeps us moving together and pushing the\nboundaries to deliver high-quality medicines. Take a glimpse into the special\nyear we've had in 2023.\n\nWatch now Becoming stronger, bolder, and simpler\n\n## Getting Medicines to All Who Need Them\n\nIncreasing access to medicines is fundamental to what we do at Teva. Learn\nmore about how we help address this challenge.\n\nDiscover More Getting Medicines to All Who Need Them\n\n## Press Releases\n\nJanuary 02, 2024\n\n### Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024...\n\nTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024 Fina\n\nDecember 28, 2023\n\n### Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nTeva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nDecember 14, 2023\n\n### Teva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic A...\n\nTeva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic Antibo\n\nDecember 06, 2023\n\n### New Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults wi...\n\nNew Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults with Mi\n\nNovember 30, 2023\n\n### Teva Completes Closing of Exclusive Collaboration Deal to Deliver\nInflammatory Bowel Disease Treatme...\n\nTeva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory\nBowel Disease Treatment\n\nNovember 20, 2023\n\n### Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nTeva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nNovember 17, 2023\n\n### Teva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nTeva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nNovember 13, 2023\n\n### Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nNovember 08, 2023\n\n### Teva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nTeva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nNovember 07, 2023\n\n### Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nTeva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nJanuary 02, 2024\n\n### Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024...\n\nTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024 Fina\n\nDecember 28, 2023\n\n### Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nTeva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nDecember 14, 2023\n\n### Teva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic A...\n\nTeva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic Antibo\n\nDecember 06, 2023\n\n### New Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults wi...\n\nNew Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults with Mi\n\nNovember 30, 2023\n\n### Teva Completes Closing of Exclusive Collaboration Deal to Deliver\nInflammatory Bowel Disease Treatme...\n\nTeva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory\nBowel Disease Treatment\n\nNovember 20, 2023\n\n### Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nTeva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nNovember 17, 2023\n\n### Teva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nTeva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nNovember 13, 2023\n\n### Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nNovember 08, 2023\n\n### Teva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nTeva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nNovember 07, 2023\n\n### Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nTeva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nJanuary 02, 2024\n\n### Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024...\n\nTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023\nFinancial Results and 2024 Fina\n\nDecember 28, 2023\n\n### Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nTeva to Present at the 42nd Annual J.P. Morgan Healthcare Conference\n\nDecember 14, 2023\n\n### Teva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic A...\n\nTeva and Biolojic Design Announce Exclusive License Agreement for the\nDevelopment of a Therapeutic Antibo\n\nDecember 06, 2023\n\n### New Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults wi...\n\nNew Post Hoc Phase 3 Data Analysis Shows AJOVY\u00ae (fremanezumab) Reduced\nMigraine Attacks in Adults with Mi\n\nNovember 30, 2023\n\n### Teva Completes Closing of Exclusive Collaboration Deal to Deliver\nInflammatory Bowel Disease Treatme...\n\nTeva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory\nBowel Disease Treatment\n\nNovember 20, 2023\n\n### Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nTeva to Present at the 6th Annual Evercore ISI HealthCONx Conference\n\nNovember 17, 2023\n\n### Teva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nTeva Announces Approval of a Generic Version of Forteo\u00ae (teriparatide\ninjection), in the U.S.\n\nNovember 13, 2023\n\n### Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI\nProgram\n\nNovember 08, 2023\n\n### Teva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nTeva Reports Third Quarter 2023 Financial Results and Increases Revenue\nGuidance\n\nNovember 07, 2023\n\n### Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nTeva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients\nBusiness\n\nView all press releases\n\nPrevious\n\nNext\n\n## Environmental, Social and Governance (ESG)\n\n## Explore the many ways we\u2019re making an impact\n\nActing responsibly and ethically in all we do helps ensure our\nsustainability\u2014allowing us to provide treatments to those who need them for\nyears to come.\n\nDiscover more Explore the many ways we\u2019re making an impact\n\n* * *\n\n## Take a closer look at what we do\n\n### Teva Statement Regarding the Attacks on Israel\n\nDiscover more\n\n### We are all in for better health\n\nDiscover more\n\n### Helping Address the Impact of Tardive Dyskinesia\n\nDiscover more\n\n### Teva + Our Suppliers = A Greater Positive Impact\n\nDiscover more\n\n### What Does It Take to Get Our Products to 200 Million People Every Day?\n\nRead more\n\n### Tools & Resources for Caregivers\n\nDiscover more\n\n### Producing Quality Products that Improve Lives\n\nDiscover more\n\n### Harnessing Biological Processes to Fight Disease\n\nRead more\n\n### A Loved One\u2019s Perspective on Living with Tardive Dyskinesia\n\nRead more\n\n### Access to Mental Health Care Program\n\nRead more\n\n### Building a Caregiver Team When Living with Schizophrenia\n\nRead more\n\n### Biosimilar Medicine Has Made a Difference to My Life\n\nRead more\n\n### Teva Statement Regarding the Attacks on Israel\n\nDiscover more\n\n### We are all in for better health\n\nDiscover more\n\n### Helping Address the Impact of Tardive Dyskinesia\n\nDiscover more\n\n### Teva + Our Suppliers = A Greater Positive Impact\n\nDiscover more\n\n### What Does It Take to Get Our Products to 200 Million People Every Day?\n\nRead more\n\n### Tools & Resources for Caregivers\n\nDiscover more\n\n### Producing Quality Products that Improve Lives\n\nDiscover more\n\n### Harnessing Biological Processes to Fight Disease\n\nRead more\n\n### A Loved One\u2019s Perspective on Living with Tardive Dyskinesia\n\nRead more\n\n### Access to Mental Health Care Program\n\nRead more\n\n### Building a Caregiver Team When Living with Schizophrenia\n\nRead more\n\n### Biosimilar Medicine Has Made a Difference to My Life\n\nRead more\n\n### Teva Statement Regarding the Attacks on Israel\n\nDiscover more\n\n### We are all in for better health\n\nDiscover more\n\n### Helping Address the Impact of Tardive Dyskinesia\n\nDiscover more\n\n### Teva + Our Suppliers = A Greater Positive Impact\n\nDiscover more\n\n### What Does It Take to Get Our Products to 200 Million People Every Day?\n\nRead more\n\n### Tools & Resources for Caregivers\n\nDiscover more\n\n### Producing Quality Products that Improve Lives\n\nDiscover more\n\n### Harnessing Biological Processes to Fight Disease\n\nRead more\n\n### A Loved One\u2019s Perspective on Living with Tardive Dyskinesia\n\nRead more\n\n### Access to Mental Health Care Program\n\nRead more\n\n### Building a Caregiver Team When Living with Schizophrenia\n\nRead more\n\n### Biosimilar Medicine Has Made a Difference to My Life\n\nRead more\n\nView all stories\n\nPrevious\n\nNext\n\n## Careers at Teva\n\n### Make a difference to people's health, every day\n\nWorking at Teva is not just a job, it\u2019s so much more than that. Here, you get\nto spend each day helping millions of people around the world enjoy healthier\nlives. At the same time, you\u2019ll be joining a dedicated team, united by the\nstrong sense that we\u2019re building something greater than ourselves\n\nExplore a Teva Career Make a difference to people's health, every day\n\n* * *\n\n## Life Effects Stories from Patients and Caregivers\n\n### Migraine and Brain Fog\n\nRead more\n\n### Explaining ADHD to Your Partner\n\nRead more\n\n### 6 Ways to Help Cope with Social Anxiety this Holiday Season\n\n### How to Deal with Being Guilt-Tripped Over Your Mental Health\n\n### What Caregiving Taught me About Holiday Magic\n\n### Love & Pain: Dating with Migraine\n\nDiscover more\n\n### Caregiver Time Management \u2013 Always a Work in Process\n\nRead more\n\n### How My Mental Health Affects My Parenting Style\n\nRead more\n\n### The Problem with Not Talking about Heart Failure\n\nRead more\n\n### Exercise With Asthma? Yes You Can!\n\nRead more\n\n### How I Learned to Stop Apologizing for My ADHD\n\nRead more\n\n### How to Let Go of Perfectionism as a Caregiver\n\nRead more\n\n### Living Life to the Fullest with Huntington\u2019s Disease\n\nRead more\n\n### A Letter to Myself: 5 Years After My Cancer Diagnosis\n\nRead more\n\n### Getting the Most from Your Vacation when You Have Migraine\n\nRead more\n\n### Being a Dad with Cystic Fibrosis\n\nRead more\n\n### Migraine and Brain Fog\n\nRead more\n\n### Explaining ADHD to Your Partner\n\nRead more\n\n### 6 Ways to Help Cope with Social Anxiety this Holiday Season\n\n### How to Deal with Being Guilt-Tripped Over Your Mental Health\n\n### What Caregiving Taught me About Holiday Magic\n\n### Love & Pain: Dating with Migraine\n\nDiscover more\n\n### Caregiver Time Management \u2013 Always a Work in Process\n\nRead more\n\n### How My Mental Health Affects My Parenting Style\n\nRead more\n\n### The Problem with Not Talking about Heart Failure\n\nRead more\n\n### Exercise With Asthma? Yes You Can!\n\nRead more\n\n### How I Learned to Stop Apologizing for My ADHD\n\nRead more\n\n### How to Let Go of Perfectionism as a Caregiver\n\nRead more\n\n### Living Life to the Fullest with Huntington\u2019s Disease\n\nRead more\n\n### A Letter to Myself: 5 Years After My Cancer Diagnosis\n\nRead more\n\n### Getting the Most from Your Vacation when You Have Migraine\n\nRead more\n\n### Being a Dad with Cystic Fibrosis\n\nRead more\n\n### Migraine and Brain Fog\n\nRead more\n\n### Explaining ADHD to Your Partner\n\nRead more\n\n### 6 Ways to Help Cope with Social Anxiety this Holiday Season\n\n### How to Deal with Being Guilt-Tripped Over Your Mental Health\n\n### What Caregiving Taught me About Holiday Magic\n\n### Love & Pain: Dating with Migraine\n\nDiscover more\n\n### Caregiver Time Management \u2013 Always a Work in Process\n\nRead more\n\n### How My Mental Health Affects My Parenting Style\n\nRead more\n\n### The Problem with Not Talking about Heart Failure\n\nRead more\n\n### Exercise With Asthma? Yes You Can!\n\nRead more\n\n### How I Learned to Stop Apologizing for My ADHD\n\nRead more\n\n### How to Let Go of Perfectionism as a Caregiver\n\nRead more\n\n### Living Life to the Fullest with Huntington\u2019s Disease\n\nRead more\n\n### A Letter to Myself: 5 Years After My Cancer Diagnosis\n\nRead more\n\n### Getting the Most from Your Vacation when You Have Migraine\n\nRead more\n\n### Being a Dad with Cystic Fibrosis\n\nRead more\n\nView All Stories\n\nPrevious\n\nNext\n\n## At Teva, we focus on the things that count\n\nWatch now\n\n\ufeff \ufeff\n\n##  At Teva, we strive to deliver quality medicines to patients around the\nworld with integrity and ethical business practices. What we do is important,\nbut how we do it is just as important. Learn more:\n\n###### Teva Code of Conduct\n\n###### Supplier Code of Conduct\n\n###### Environmental, Social and Governance at Teva\n\n###### All Corporate Governance & Policy Documents\n\n  * Contact Us\n  * Terms of Use\n  * Social Media Guidelines\n  * Teva api\n  * Medis\n\n  * Sitemap\n  * Data Privacy\n  * Pharmacovigilance Privacy Notice\n  * Accessibility Statement\n  * Cookie Settings\n\n#####  Follow us\n\n  * Facebook\n  * Twitter\n  * Linkedin\n  * Youtube\n\nCopyright \u00a9 2024 Teva Pharmaceutical Industries Ltd.\n\nClick here to back to top\n\n### You are about to leave the Teva Pharmaceuticals global website\n\nClose\n\nThe website you are about to access may be governed by different regional\npolicies, regulations or advertising codes. Please be sure to read the privacy\npolicy and terms of use of the websites that you visit.\n\nTeva Pharmaceuticals is not responsible for the accuracy or compliance with\nlaws of information on any third party websites.\n\n**Do you wish to proceed?**\n\nGo to site\n\n## Privacy Preference Centre\n\n  * ### Your Privacy\n\n  * ### Strictly Necessary Cookies\n\n  * ### Targeting Cookies\n\n  * ### Functional Cookies\n\n  * ### Performance Cookies\n\n#### Your Privacy\n\nWhen you visit any website, it may store or retrieve information on your\nbrowser, mostly in the form of cookies. This information might be about you,\nyour preferences or your device and is mostly used to make the site work as\nyou expect it to. The information does not usually directly identify you, but\nit can give you a more personalized web experience. Because we respect your\nright to privacy, you can choose not to allow some types of cookies. Click on\nthe different category headings to find out more and change our default\nsettings. However, blocking some types of cookies may impact your experience\nof the site and the services we are able to offer.  \nMore information\n\n#### Strictly Necessary Cookies\n\nAlways Active\n\nThese cookies are necessary for the website to function and cannot be switched\noff in our systems. They are usually only set in response to actions made by\nyou which amount to a request for services, such as setting your privacy\npreferences, logging in or filling in forms. You can set your browser to block\nor alert you about these cookies, but some parts of the site will not then\nwork.\n\nCookies Details\u200e\n\n#### Targeting Cookies\n\nTargeting Cookies Inactive\n\nThese cookies may be set through our site by our advertising partners. They\nmay be used by those companies to build a profile of your interests and show\nyou relevant adverts on other sites. They do not store directly personal\ninformation, but are based on uniquely identifying your browser and internet\ndevice. If you do not allow these cookies, you will experience less targeted\nadvertising.\n\nCookies Details\u200e\n\n#### Functional Cookies\n\nFunctional Cookies Inactive\n\nThese cookies enable the website to provide enhanced functionality and\npersonalisation. They may be set by us or by third party providers whose\nservices we have added to our pages. If you do not allow these cookies then\nsome or all of these services may not function properly.\n\nCookies Details\u200e\n\n#### Performance Cookies\n\nPerformance Cookies Inactive\n\nThese cookies allow us to count visits and traffic sources so we can measure\nand improve the performance of our site. They help us to know which pages are\nthe most and least popular and see how visitors move around the site. All\ninformation these cookies collect is aggregated and therefore may be non-\ndirectly identifiable. If you do not allow these cookies we will not know when\nyou have visited our site, and will not be able to monitor its performance.\n\nCookies Details\u200e\n\nBack Button Back\n\nVendor Search\n\nFilter Button\n\nConsent Leg.Interest\n\ncheckbox label label\n\ncheckbox label label\n\ncheckbox label label\n\n  * ### \n\n####\n\nView Third Party Cookies\n\n    * Name\n\ncookie name\n\nClear\n\ncheckbox label label\n\nApply Cancel\n\nConfirm My Choices\n\nAllow All\n\n### Cookies\n\nWe would like to collect some of your data to enhance your browsing\nexperience, analyse, and measure your engagement with our content. By clicking\n[Accept] you consent to this and to sharing this data with our partners,\nincluding to serve you more relevant ads on other websites. If you continue\nwithout accepting, this cannot take place or will be less accurate. You can\nchange your mind at any time. To find out more about your rights, our\npractices, the data we collect and our partners, click here.\n\nAcceptReject AllYour Choices\n\n",
    "links": "[{\"link\": \"https://tevacanada.com\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/Worldwide/belarus/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/Worldwide/kyrgyzstan/\", \"text\": \"\"}, {\"link\": \"https://tevapharm.dk\", \"text\": \"\"}, {\"link\": \"https://tevacanada.com\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/Worldwide/belarus/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/Worldwide/kyrgyzstan/\", \"text\": \"\"}, {\"link\": \"https://tevapharm.dk\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/\", \"text\": \"News & Media\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/our-purpose/\", \"text\": \"\\n        Our Purpose\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/teva-corporate-officers/\", \"text\": \"\\n        Corporate Officers\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/board-of-directors/\", \"text\": \"\\n        Board of Directors\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/corporate-governance-documents/\", \"text\": \"\\n        Governance & Policy Documents\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/our-values/\", \"text\": \"\\n        Our Values\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/teva-facts-figures/\", \"text\": \"\\n        Teva Facts & Figures\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/teva-history/\", \"text\": \"\\n        Our History\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/supply-chain/\", \"text\": \"\\n        Teva\u2019s Global Supply Chain\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/compliance-and-integrity/\", \"text\": \"\\n        Compliance and Integrity\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/generic-medicines/\", \"text\": \"\\n        Generic Medicines\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/specialty-therapeutic-areas/\", \"text\": \"\\n        Innovative Therapeutic Areas\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/biopharmaceuticals/\", \"text\": \"\\n        Biopharmaceuticals\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/research/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/research/pipeline/\", \"text\": \"\\n        Our Pipeline\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/teva-clinical-trials\", \"text\": \"\\n        Clinical Trials\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/research/iss-cr/\", \"text\": \"\\n        Collaborative Research & ISS\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/teva-medical-information/\", \"text\": \"\\n        Medical Information\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/consumer-healthcare/\", \"text\": \"\\n        Consumer Healthcare\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/medis/\", \"text\": \"\\n        Out-Licensing Generic Pharmaceuticals\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/teva-api/\", \"text\": \"\\n        Teva api\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/our-quality/\", \"text\": \"\\n        Quality Products\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/all-stories/\", \"text\": \"\\n        Life Effects\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/caring-for-the-caregivers/\", \"text\": \"\\n        Caregivers\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/humanizing-health/\", \"text\": \"\\n        Humanizing Health\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/product-focus/research/patient-safety-is-our-priority/\", \"text\": \"\\n        Patient Safety \\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/covid-19-updates-and-resources/\", \"text\": \"\\n        COVID Updates\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/rise-of-the-superbugs/\", \"text\": \"\\n        Antimicrobial Resistance\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/teva-clinical-trials/\", \"text\": \"\\n        Clinical Trials\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/esg-progress-report/\", \"text\": \"\\n        ESG Progress Report\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/getting-medicines-who-need/\", \"text\": \"\\n        Access to Medicine\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/protecting-our-planet/\", \"text\": \"\\n        Protecting our Planet \\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/doing-business-the-right-way/\", \"text\": \"\\n        Ethics & Compliance\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/economic-impact-report/\", \"text\": \"\\n        Economic Impact\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/maintaining-responsible-supply-chain/\", \"text\": \"\\n        Responsible Suppliers\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/giving-back-to-our-communities/\", \"text\": \"\\n        Community Giving\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/what-we-do-at-teva/\", \"text\": \"\\n        What we do\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/inclusion-and-diversity-at-teva/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/your-career/gender-equality\", \"text\": \"\\n        Gender Equality\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/your-career/pride-teva/\", \"text\": \"\\n        Celebrating Pride at Teva\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/life-at-teva/\", \"text\": \"\\n        Life at Teva\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/growth-at-teva/\", \"text\": \"\\n        Growth at Teva\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/benefits-wellbeing/\", \"text\": \"\\n        Benefits & Wellbeing\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/changing-industry/\", \"text\": \"\\n        Changing Industry\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/how-we-hire/\", \"text\": \"\\n        How we Hire\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/our-people/\", \"text\": \"\\n        Our People\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/contact-us/\", \"text\": \"\\n        Contact Us\\n\\n    \"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/getting-medicines-who-need/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-2024-fina/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-42nd-annual-j.p.-morgan-healthcare-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-biolojic-design-announce-exclusive-license-agreement-for-the-development-of-a-therapeutic-antibo/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/new-post-hoc-phase-3-data-analysis-shows-ajovy-fremanezumab-reduced-migraine-attacks-in-adults-with-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-completes-closing-of-exclusive-collaboration-deal-to-deliver-inflammatory-bowel-disease-treatment/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-6th-annual-evercore-isi-healthconx-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-announces-approval-of-a-generic-version-of-forteo-teriparatide-injection-in-the-u.s/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-royalty-pharma-collaborate-to-further-accelerate-olanzapine-lai-program/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-reports-third-quarter-2023-financial-results-and-increases-revenue-guidance/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-appoints-new-ceo-for-teva-api-its-active-pharmaceutical-ingredients-business/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-2024-fina/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-42nd-annual-j.p.-morgan-healthcare-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-biolojic-design-announce-exclusive-license-agreement-for-the-development-of-a-therapeutic-antibo/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/new-post-hoc-phase-3-data-analysis-shows-ajovy-fremanezumab-reduced-migraine-attacks-in-adults-with-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-completes-closing-of-exclusive-collaboration-deal-to-deliver-inflammatory-bowel-disease-treatment/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-6th-annual-evercore-isi-healthconx-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-announces-approval-of-a-generic-version-of-forteo-teriparatide-injection-in-the-u.s/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-royalty-pharma-collaborate-to-further-accelerate-olanzapine-lai-program/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-reports-third-quarter-2023-financial-results-and-increases-revenue-guidance/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-appoints-new-ceo-for-teva-api-its-active-pharmaceutical-ingredients-business/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-2024-fina/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-42nd-annual-j.p.-morgan-healthcare-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-biolojic-design-announce-exclusive-license-agreement-for-the-development-of-a-therapeutic-antibo/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/new-post-hoc-phase-3-data-analysis-shows-ajovy-fremanezumab-reduced-migraine-attacks-in-adults-with-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-completes-closing-of-exclusive-collaboration-deal-to-deliver-inflammatory-bowel-disease-treatment/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-present-at-the-6th-annual-evercore-isi-healthconx-conference/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-announces-approval-of-a-generic-version-of-forteo-teriparatide-injection-in-the-u.s/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-and-royalty-pharma-collaborate-to-further-accelerate-olanzapine-lai-program/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-reports-third-quarter-2023-financial-results-and-increases-revenue-guidance/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-appoints-new-ceo-for-teva-api-its-active-pharmaceutical-ingredients-business/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/standing-with-israel-teva-statement-regarding-the-attacks-on-israeli-civilians/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/we-are-all-in-for-better-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/helping-address-the-impact-of-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/teva-supplier-webinar-tevapharm/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/generics-medicine-people-global/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/product-focus/our-quality/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/what-are-biologics-teva-discovery-sydney/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/a-loved-ones-perspective-on-living-with-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-provide-second-round-of-funding-to-clinics-in-california-florida-and-new-jersey-as-part-of-$2-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/building-a-caregiver-team-when-living-with-schizophrenia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/rachna-sood/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/standing-with-israel-teva-statement-regarding-the-attacks-on-israeli-civilians/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/we-are-all-in-for-better-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/helping-address-the-impact-of-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/teva-supplier-webinar-tevapharm/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/generics-medicine-people-global/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/product-focus/our-quality/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/what-are-biologics-teva-discovery-sydney/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/a-loved-ones-perspective-on-living-with-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-provide-second-round-of-funding-to-clinics-in-california-florida-and-new-jersey-as-part-of-$2-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/building-a-caregiver-team-when-living-with-schizophrenia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/rachna-sood/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/standing-with-israel-teva-statement-regarding-the-attacks-on-israeli-civilians/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/we-are-all-in-for-better-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/helping-address-the-impact-of-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/teva-supplier-webinar-tevapharm/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/news-and-media/feature-stories/generics-medicine-people-global/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/product-focus/our-quality/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/what-are-biologics-teva-discovery-sydney/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/a-loved-ones-perspective-on-living-with-tardive-dyskinesia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/latest-news/teva-to-provide-second-round-of-funding-to-clinics-in-california-florida-and-new-jersey-as-part-of-$2-mi/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/building-a-caregiver-team-when-living-with-schizophrenia/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/rachna-sood/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/feature-stories/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/your-career/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/migraine-brain-fog/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/tips-to-communicate-adhd-to-your-partner/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/ways-to-help-cope-with-social-anxiety-this-christmas/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-deal-with-being-guilt-tripped-over-your-mental-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/what-caregiving-taught-me-about-holiday-magic/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/dating-with-migraine/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/caregiver-time-management/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/mental-health-affects-parenting-style/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/the-problem-with-not-talking-about-heart-failure/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/exercise-with-asthma-yes-you-can/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/stop-apologizing-for-adhd/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-let-go-of-perfectionism-as-a-caregiver/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/living-life-to-the-fullest-with-huntingtons-disease/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-letter-to-myself-5-years-after-my-cancer-diagnosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/plan-migraine-friendly-vacation/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-dad-with-cystic-fibrosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/migraine-brain-fog/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/tips-to-communicate-adhd-to-your-partner/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/ways-to-help-cope-with-social-anxiety-this-christmas/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-deal-with-being-guilt-tripped-over-your-mental-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/what-caregiving-taught-me-about-holiday-magic/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/dating-with-migraine/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/caregiver-time-management/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/mental-health-affects-parenting-style/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/the-problem-with-not-talking-about-heart-failure/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/exercise-with-asthma-yes-you-can/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/stop-apologizing-for-adhd/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-let-go-of-perfectionism-as-a-caregiver/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/living-life-to-the-fullest-with-huntingtons-disease/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-letter-to-myself-5-years-after-my-cancer-diagnosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/plan-migraine-friendly-vacation/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-dad-with-cystic-fibrosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/migraine-brain-fog/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/tips-to-communicate-adhd-to-your-partner/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/ways-to-help-cope-with-social-anxiety-this-christmas/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-deal-with-being-guilt-tripped-over-your-mental-health/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/what-caregiving-taught-me-about-holiday-magic/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/dating-with-migraine/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/caregiver-time-management/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/mental-health-affects-parenting-style/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/the-problem-with-not-talking-about-heart-failure/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/exercise-with-asthma-yes-you-can/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/stop-apologizing-for-adhd/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/how-to-let-go-of-perfectionism-as-a-caregiver/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/living-life-to-the-fullest-with-huntingtons-disease/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-letter-to-myself-5-years-after-my-cancer-diagnosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/plan-migraine-friendly-vacation/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/a-dad-with-cystic-fibrosis/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/patients-and-caregivers/all-stories/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/teva-corporate-video/\", \"text\": \"Watch now\"}, {\"link\": \"https://www.tevapharm.com/globalassets/tevapharm-vision-files/teva_codeofconduct_12feb2019_final.pdf\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/supplier-code-of-conduct/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-impact/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/corporate-governance-documents/\", \"text\": \"\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/contact-us/\", \"text\": \"Contact Us\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/legal-notes/\", \"text\": \"Terms of Use\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/news-and-media/teva-social-media-guidelines/\", \"text\": \"Social Media Guidelines\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/sitemap-page/\", \"text\": \"Sitemap\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/data-privacy/\", \"text\": \"Data Privacy\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/teva-privacy-notice/\", \"text\": \"Pharmacovigilance Privacy Notice\"}, {\"link\": \"https://www.tevapharm.com/en/tevapharm/our-company/corporate-governance/accessibility-statement/\", \"text\": \"Accessibility Statement\"}, {\"link\": \"https://www.tevapharm.com/our-company/corporate-governance/data-privacy/\", \"text\": \"More information\"}, {\"link\": \"https://www.tevapharm.com/our-company/corporate-governance/data-privacy/\", \"text\": \" here.\"}]"
}